Page 4 - Ableson Tyrosine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Inhibikase Therapeutics Initiates Development of Second Generation c-Abl inhibitors and names IkT-148009 as risvodetinib

BOSTON - Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson s disease, Parkinson s-related.

United statesMilton wernerMiltonh wernerWorld health organizationExchange commissionAmerican medical associationInhibikase or companyInhibikase therapeutics incAbelson tyrosine kinasesInternational non proprietaryHealth organizationAbelson tyrosine kinaseAbleson tyrosineMultiple system atrophyPrivate securities litigation reform actNews publishing

Inhibikase Therapeutics Announces Completion of the 501 Bioequivalence Study of IkT-001Pro

/PRNewswire/ Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase.

United statesMilton wernerAlex loboMiltonh wernerInhibikase therapeutics incPrnewswire inhibikase therapeutics incCompany contactSternir incExchange commissionInhibikase or companyAbelson tyrosine kinasesChief executive officerAbelson tyrosine kinaseOrphan drug designationChronic myelogenous leukemiaAbleson tyrosine

Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity

/PRNewswire/ Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase.

United statesMiltonh wernerAlex loboInhibikase therapeutics incSternir incExchange commissionInhibikase or companyCompany contactInhibikase therapeuticsAbelson tyrosine kinasesChief executive officerUpcoming milestonesNasdaq listing requirementsNasdaq listing ruleAbelson tyrosine kinaseAbleson tyrosine

Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity

Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United statesAlex loboMiltonh wernerExchange commissionInhibikase therapeutics incInhibikase or companySternir incCompany contactInhibikase therapeuticsAbelson tyrosine kinasesChief executive officerUpcoming milestonesNasdaq listing requirementsNasdaq listing ruleAbelson tyrosine kinaseAbleson tyrosine

Inhibikase Therapeutics to Report Second Quarter Financial Results on August 14, 2023

BOSTON and ATLANTA, Aug. 7, 2023 /PRNewswire/ Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of.

United statesMiltonh wernerAlex loboInhibikase therapeutics incCompany contactInhibikase or companySternir incPrnewswire inhibikase therapeutics incAbelson tyrosine kinasesAbelson tyrosine kinaseAbleson tyrosineMultiple system atrophy